Plaintiff
Defendant
- Parties: The plaintiffs were Boehringer Ingelheim (Canada) Ltd and Boehringer Ingelheim International GMBH, while the defendant was Jamp Pharma Corporation.
- Subject Matter: This case involved an action brought under the Patented Medicines (NOC) Regulations.
- Date: The hearing was set on Feb. 20, 2024.
- Venue: This was a federal case before the Federal Court.
- Amount: No financial award was specified.
Court
Federal CourtCase Number
T-2276-22Practice Area
Intellectual propertyAmount
Winner
Trial Start Date
31 October 2022Download documents